Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical substanceL01EP02Tepotinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
At a glance
- ATC code
- L01EP02
- Registers
- 9
- Registrations
- 9
- With their own page
- 9
- Companies
- 6
All medicines with Tepotinib
Human medicines from every register that match Tepotinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
9 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tepmetko | United States | 225MG BASE | tablet | Marketed | Emd Serono INC |
| Tepmetko | European Union | Authorised | Merck Europe B.V. | ||
| Tepmetko | Canada | 225 MG | Tablet | Marketed | Emd Serono, A Division of Emd INC., Canada |
| Tepmetko 225 MG Comprimidos Recubiertos con Pelicula | Spain | 250 mg | comprimido recubierto con película | Marketed | Merck Europe B.V. |
| Tepmetko | Brazil | Authorised | Merck S/A | ||
| Tepmetko 225 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Merck Europe B.V. | |
| Tepmetko | Croatia | Marketed | |||
| Tepmetko Film-Coated Tablet 225MG | Singapore | 225mg | tablet, film coated | Authorised | Merck Pte. LTD. |
| TEPMETKO film-coated Tablets 225 mg | Taiwan | 膜衣錠 | Authorised | 台灣默克股份有限公司 |